Russell Investments Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-915
| Closed | -$17.3K | – | 3761 |
|
2024
Q3 | $17.3K | Sell |
915
-185
| -17% | -$3.5K | ﹤0.01% | 2988 |
|
2024
Q2 | $15.9K | Buy |
1,100
+185
| +20% | +$2.68K | ﹤0.01% | 2979 |
|
2024
Q1 | $14.2K | Hold |
915
| – | – | ﹤0.01% | 2811 |
|
2023
Q4 | $25.6K | Hold |
915
| – | – | ﹤0.01% | 2715 |
|
2023
Q3 | $43.6K | Hold |
915
| – | – | ﹤0.01% | 2773 |
|
2023
Q2 | $87.7K | Hold |
915
| – | – | ﹤0.01% | 2631 |
|
2023
Q1 | $104K | Hold |
915
| – | – | ﹤0.01% | 2582 |
|
2022
Q4 | $102K | Hold |
915
| – | – | ﹤0.01% | 2670 |
|
2022
Q3 | $117K | Sell |
915
-2,350
| -72% | -$300K | ﹤0.01% | 2645 |
|
2022
Q2 | $222K | Sell |
3,265
-284
| -8% | -$19.3K | ﹤0.01% | 2517 |
|
2022
Q1 | $504K | Sell |
3,549
-1,157
| -25% | -$164K | ﹤0.01% | 2222 |
|
2021
Q4 | $782K | Buy |
4,706
+3,791
| +414% | +$630K | ﹤0.01% | 2271 |
|
2021
Q3 | $127K | Hold |
915
| – | – | ﹤0.01% | 2852 |
|
2021
Q2 | $436K | Hold |
915
| – | – | ﹤0.01% | 2651 |
|
2021
Q1 | $376K | Buy |
915
+439
| +92% | +$180K | ﹤0.01% | 2634 |
|
2020
Q4 | $233K | Buy |
+476
| New | +$233K | ﹤0.01% | 2717 |
|
2020
Q3 | – | Sell |
-3,702
| Closed | -$352K | – | 3226 |
|
2020
Q2 | $352K | Buy |
3,702
+535
| +17% | +$50.9K | ﹤0.01% | 2518 |
|
2020
Q1 | $225K | Buy |
3,167
+219
| +7% | +$15.6K | ﹤0.01% | 2503 |
|
2019
Q4 | $202K | Buy |
+2,948
| New | +$202K | ﹤0.01% | 2710 |
|
2019
Q2 | – | Sell |
-1,230
| Closed | -$169K | – | 2917 |
|
2019
Q1 | $169K | Buy |
1,230
+120
| +11% | +$16.5K | ﹤0.01% | 2645 |
|
2018
Q4 | $101K | Buy |
+1,110
| New | +$101K | ﹤0.01% | 2726 |
|
2018
Q2 | – | Sell |
-580
| Closed | -$85K | – | 2930 |
|
2018
Q1 | $85K | Buy |
580
+85
| +17% | +$12.5K | ﹤0.01% | 2770 |
|
2017
Q4 | $102K | Buy |
+495
| New | +$102K | ﹤0.01% | 2771 |
|
2017
Q1 | – | Sell |
-186
| Closed | -$37K | – | 3038 |
|
2016
Q4 | $37K | Buy |
+186
| New | +$37K | ﹤0.01% | 3003 |
|